IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of several MS risk genes, the majority of which have known immune-related functions. However, disease heterogeneity and low tissue accessibility hin...
Uložené v:
| Vydané v: | The Journal of immunology (1950) Ročník 185; číslo 11; s. 6883 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.12.2010
|
| Predmet: | |
| ISSN: | 1550-6606, 1550-6606 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of several MS risk genes, the majority of which have known immune-related functions. However, disease heterogeneity and low tissue accessibility hinder functional studies of established MS risk genes. For this reason, the MS model experimental autoimmune encephalomyelitis (EAE) is often used to study neuroinflammatory disease mechanisms. In this study, we performed high-resolution linkage analysis in a rat advanced intercross line to identify an EAE-regulating quantitative trait locus, Eae29, on rat chromosome 1. Eae29 alleles from the resistant strain both conferred milder EAE and lower production of proinflammatory molecules in macrophages, as demonstrated by the congenic line, DA.PVG-Eae29 (Dc1P). The soluble IL-22R α2 gene (Il-22ra2) lies within the Eae29 locus, and its expression was reduced in Dc1P, both in activated macrophages and splenocytes from immunized rats. Moreover, a single nucleotide polymorphism located at the end of IL-22RA2 associated with MS risk in a combined Swedish and Norwegian cohort comprising 5019 subjects, displaying an odds ratio of 1.26 (p = 8.0 × 10(-4)). IL-22 and its receptors have been implicated in chronic inflammation, suggesting that IL-22RA2 regulates a central immune pathway. Through a combined approach including genetic and immunological investigation in an animal model and large-scale association studies of MS patients, we establish IL-22RA2 as an MS risk gene. |
|---|---|
| AbstractList | Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of several MS risk genes, the majority of which have known immune-related functions. However, disease heterogeneity and low tissue accessibility hinder functional studies of established MS risk genes. For this reason, the MS model experimental autoimmune encephalomyelitis (EAE) is often used to study neuroinflammatory disease mechanisms. In this study, we performed high-resolution linkage analysis in a rat advanced intercross line to identify an EAE-regulating quantitative trait locus, Eae29, on rat chromosome 1. Eae29 alleles from the resistant strain both conferred milder EAE and lower production of proinflammatory molecules in macrophages, as demonstrated by the congenic line, DA.PVG-Eae29 (Dc1P). The soluble IL-22R α2 gene (Il-22ra2) lies within the Eae29 locus, and its expression was reduced in Dc1P, both in activated macrophages and splenocytes from immunized rats. Moreover, a single nucleotide polymorphism located at the end of IL-22RA2 associated with MS risk in a combined Swedish and Norwegian cohort comprising 5019 subjects, displaying an odds ratio of 1.26 (p = 8.0 × 10(-4)). IL-22 and its receptors have been implicated in chronic inflammation, suggesting that IL-22RA2 regulates a central immune pathway. Through a combined approach including genetic and immunological investigation in an animal model and large-scale association studies of MS patients, we establish IL-22RA2 as an MS risk gene. Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of several MS risk genes, the majority of which have known immune-related functions. However, disease heterogeneity and low tissue accessibility hinder functional studies of established MS risk genes. For this reason, the MS model experimental autoimmune encephalomyelitis (EAE) is often used to study neuroinflammatory disease mechanisms. In this study, we performed high-resolution linkage analysis in a rat advanced intercross line to identify an EAE-regulating quantitative trait locus, Eae29, on rat chromosome 1. Eae29 alleles from the resistant strain both conferred milder EAE and lower production of proinflammatory molecules in macrophages, as demonstrated by the congenic line, DA.PVG-Eae29 (Dc1P). The soluble IL-22R α2 gene (Il-22ra2) lies within the Eae29 locus, and its expression was reduced in Dc1P, both in activated macrophages and splenocytes from immunized rats. Moreover, a single nucleotide polymorphism located at the end of IL-22RA2 associated with MS risk in a combined Swedish and Norwegian cohort comprising 5019 subjects, displaying an odds ratio of 1.26 (p = 8.0 × 10(-4)). IL-22 and its receptors have been implicated in chronic inflammation, suggesting that IL-22RA2 regulates a central immune pathway. Through a combined approach including genetic and immunological investigation in an animal model and large-scale association studies of MS patients, we establish IL-22RA2 as an MS risk gene.Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of several MS risk genes, the majority of which have known immune-related functions. However, disease heterogeneity and low tissue accessibility hinder functional studies of established MS risk genes. For this reason, the MS model experimental autoimmune encephalomyelitis (EAE) is often used to study neuroinflammatory disease mechanisms. In this study, we performed high-resolution linkage analysis in a rat advanced intercross line to identify an EAE-regulating quantitative trait locus, Eae29, on rat chromosome 1. Eae29 alleles from the resistant strain both conferred milder EAE and lower production of proinflammatory molecules in macrophages, as demonstrated by the congenic line, DA.PVG-Eae29 (Dc1P). The soluble IL-22R α2 gene (Il-22ra2) lies within the Eae29 locus, and its expression was reduced in Dc1P, both in activated macrophages and splenocytes from immunized rats. Moreover, a single nucleotide polymorphism located at the end of IL-22RA2 associated with MS risk in a combined Swedish and Norwegian cohort comprising 5019 subjects, displaying an odds ratio of 1.26 (p = 8.0 × 10(-4)). IL-22 and its receptors have been implicated in chronic inflammation, suggesting that IL-22RA2 regulates a central immune pathway. Through a combined approach including genetic and immunological investigation in an animal model and large-scale association studies of MS patients, we establish IL-22RA2 as an MS risk gene. |
| Author | Ockinger, Johan Becanovic, Kristina Laaksonen, Hannes Celius, Elisabeth G Beyeen, Amennai D Harbo, Hanne F Kockum, Ingrid Hillert, Jan Stridh, Pernilla Lassmann, Hans Jagodic, Maja Harris, Robert A Alfredsson, Lars Adzemovic, Milena Z Olsson, Tomas |
| Author_xml | – sequence: 1 givenname: Amennai D surname: Beyeen fullname: Beyeen, Amennai D email: amennai.beyeen@ki.se organization: Neuroimmunology Unit, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. amennai.beyeen@ki.se – sequence: 2 givenname: Milena Z surname: Adzemovic fullname: Adzemovic, Milena Z – sequence: 3 givenname: Johan surname: Ockinger fullname: Ockinger, Johan – sequence: 4 givenname: Pernilla surname: Stridh fullname: Stridh, Pernilla – sequence: 5 givenname: Kristina surname: Becanovic fullname: Becanovic, Kristina – sequence: 6 givenname: Hannes surname: Laaksonen fullname: Laaksonen, Hannes – sequence: 7 givenname: Hans surname: Lassmann fullname: Lassmann, Hans – sequence: 8 givenname: Robert A surname: Harris fullname: Harris, Robert A – sequence: 9 givenname: Jan surname: Hillert fullname: Hillert, Jan – sequence: 10 givenname: Lars surname: Alfredsson fullname: Alfredsson, Lars – sequence: 11 givenname: Elisabeth G surname: Celius fullname: Celius, Elisabeth G – sequence: 12 givenname: Hanne F surname: Harbo fullname: Harbo, Hanne F – sequence: 13 givenname: Ingrid surname: Kockum fullname: Kockum, Ingrid – sequence: 14 givenname: Maja surname: Jagodic fullname: Jagodic, Maja – sequence: 15 givenname: Tomas surname: Olsson fullname: Olsson, Tomas |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21041731$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLAzEUhYNU7EP3riQ7V1Nv0jQzsyzFR6EgiK5LZnJjU_IYJxnUf2_BCq7Ot_g4HM6UjEIMSMg1g7kAUd8drPdDiG7OANii5mdkwpZLKKQEOfrHYzJN6QAAEri4IGPOQLBywSak22wLzl9WnKqUYmtVxkQ_bd5TP7hsO4c0tQ77mGyiKmjqVdvHbq_ekaIx2ObYU4_tXgWbfKI2UPzqsLceQ1aOBhz6aINxynuVbQyX5Nwol_DqlDPy9nD_un4qts-Pm_VqW7SCQS4aU4GWsl7UKCrWoNbiCFBrhQYbA2h0WZZNhSCNqoRAqIAvaw4aa6Ml5zNy-9vb9fFjwJR33qYWnVMB45B2FVRCMibLo3lzMofGo951x_Gq_979ncR_AGBxbv4 |
| CitedBy_id | crossref_primary_10_1007_s10753_014_0059_z crossref_primary_10_3390_pharmaceutics15030728 crossref_primary_10_1186_s12974_015_0335_3 crossref_primary_10_1177_1721727X1301100121 crossref_primary_10_3390_cells9010175 crossref_primary_10_1093_hmg_ddt343 crossref_primary_10_1111_sji_12057 crossref_primary_10_1371_journal_pone_0113025 crossref_primary_10_3389_fphar_2022_958022 crossref_primary_10_3389_fimmu_2021_688066 crossref_primary_10_1089_ars_2011_4440 crossref_primary_10_1111_j_1365_3083_2012_02753_x crossref_primary_10_1111_jpi_12442 crossref_primary_10_1517_14728222_2013_844461 crossref_primary_10_1016_j_cyto_2024_156617 crossref_primary_10_1002_acn3_84 crossref_primary_10_1111_imm_12552 crossref_primary_10_1212_NXG_0000000000000087 crossref_primary_10_1186_1471_2164_15_391 crossref_primary_10_3389_fimmu_2020_00947 crossref_primary_10_4049_jimmunol_1900400 crossref_primary_10_1016_j_intimp_2015_08_016 crossref_primary_10_3389_fimmu_2018_02934 crossref_primary_10_1371_journal_pone_0173780 crossref_primary_10_3390_ijms25052589 crossref_primary_10_1016_j_expneurol_2023_114351 crossref_primary_10_3389_fimmu_2021_766586 crossref_primary_10_1016_j_molimm_2016_12_020 crossref_primary_10_1586_1744666X_2014_884461 crossref_primary_10_1007_s10048_014_0396_y crossref_primary_10_1016_j_cytogfr_2012_07_002 crossref_primary_10_1155_2012_260473 crossref_primary_10_1007_s12031_015_0643_1 crossref_primary_10_1016_j_cyto_2014_09_011 crossref_primary_10_1016_j_imlet_2019_10_006 crossref_primary_10_1002_iid3_1213 crossref_primary_10_1186_s12929_020_00673_8 crossref_primary_10_1007_s00401_024_02764_4 crossref_primary_10_1111_imm_13340 crossref_primary_10_3390_cells9020482 crossref_primary_10_3389_fncel_2018_00458 crossref_primary_10_1016_j_jneuroim_2013_04_021 crossref_primary_10_1371_journal_pone_0083504 crossref_primary_10_3389_fgene_2025_1519677 crossref_primary_10_3390_ani13020308 crossref_primary_10_1007_s11010_012_1430_8 crossref_primary_10_1016_j_amjms_2018_08_018 crossref_primary_10_1016_j_jns_2017_12_022 crossref_primary_10_1016_j_cytogfr_2014_04_005 crossref_primary_10_1111_imr_13122 crossref_primary_10_1038_gene_2014_36 crossref_primary_10_1038_gene_2011_44 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.4049/jimmunol.1001392 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1550-6606 |
| ExternalDocumentID | 21041731 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX ABCQX ABDFA ABEJV ABGNP ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AETEA AFFNX AFHIN AFOSN AFRAH AHMMS AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS ARBBW BAWUL BCRHZ BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 K-O KQ8 L7B NPM OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHI ROX RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG ZE2 ZGI 0R~ 7X8 ABXVV KOP |
| ID | FETCH-LOGICAL-c410t-bf80d66939e481bedd4e4809daefebf0efd777b8e06fa844e08025920de9fd622 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 60 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000284311500055&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1550-6606 |
| IngestDate | Sun Nov 09 04:52:51 EST 2025 Thu Apr 03 07:07:31 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c410t-bf80d66939e481bedd4e4809daefebf0efd777b8e06fa844e08025920de9fd622 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/185/11/6883/1322403/1001392.pdf |
| PMID | 21041731 |
| PQID | 808461167 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_808461167 pubmed_primary_21041731 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-12-01 |
| PublicationDateYYYYMMDD | 2010-12-01 |
| PublicationDate_xml | – month: 12 year: 2010 text: 2010-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of immunology (1950) |
| PublicationTitleAlternate | J Immunol |
| PublicationYear | 2010 |
| SSID | ssj0006024 |
| Score | 2.282136 |
| Snippet | Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the CNS. Recent advances in whole-genome screening tools have enabled discovery of... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 6883 |
| SubjectTerms | Animals Animals, Congenic Crosses, Genetic Encephalomyelitis, Autoimmune, Experimental - genetics Encephalomyelitis, Autoimmune, Experimental - immunology Encephalomyelitis, Autoimmune, Experimental - pathology False Positive Reactions Female Follow-Up Studies Genetic Association Studies - methods Genetic Predisposition to Disease Humans Immunity, Innate - genetics Macrophages, Peritoneal - immunology Macrophages, Peritoneal - metabolism Macrophages, Peritoneal - pathology Male Multiple Sclerosis - genetics Multiple Sclerosis - immunology Multiple Sclerosis - pathology Rats Rats, Inbred Strains Receptors, Interleukin - genetics Receptors, Interleukin - metabolism Receptors, Interleukin - physiology Risk Factors Severity of Illness Index |
| Title | IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21041731 https://www.proquest.com/docview/808461167 |
| Volume | 185 |
| WOSCitedRecordID | wos000284311500055&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qVLz4Mb_mFzl4LcvSNG1OMkRR2MYQhd1G2rxgxbVznYL_vS9tN72IBw8t7aGlJL--90vex4-Qy0gqEVglPKGtkzCLYw-PBG_BB8m19eOyiWsvHAyi0UgN69ycok6rXNjE0lCbPHF75O2Ioad0QYOr6ZvnRKNccLVW0FglDR-ZjAN1OPpuFi5ZpWmLJNyTSNSrKKVATtx-SV31Rf5atiDyyzjoL_yy9DO3O__8wl2yXRNM2q0QsUdWIGuSjUpy8rNJNvt1MH2fTO97HucPXU51PUdQULcvSxdZhrTAV6AbTQuqM0Mn2ul9PaMFolUaSD6jE3Clw2kxKWia0Z96AbRslYkARsxV9ZEH5On25vH6zqsFGLxEdNjci23EjJTKVyCQ3oIxAi-YMhosxJaBNWEYxhEwaXUkBLjC3UBxZkBZIzk_JGtZnsExoQySDg-RC8iYCS21diupwLCAJ0FsVdQidDGoYwS4i1roDPL3Yrwc1hY5qiZmPK0acYxxuSo6od85-fvhU7LFl4koZ6Rh8eeGc7KefMzTYnZRAgfPg2H_C5h80II |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-22RA2+associates+with+multiple+sclerosis+and+macrophage+effector+mechanisms+in+experimental+neuroinflammation&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Beyeen%2C+Amennai+D&rft.au=Adzemovic%2C+Milena+Z&rft.au=Ockinger%2C+Johan&rft.au=Stridh%2C+Pernilla&rft.date=2010-12-01&rft.issn=1550-6606&rft.eissn=1550-6606&rft.volume=185&rft.issue=11&rft.spage=6883&rft_id=info:doi/10.4049%2Fjimmunol.1001392&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-6606&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-6606&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-6606&client=summon |